Skip to content

Nutritional supplementation in the prevention and treatment of anemia

Effectiveness of nutritional supplementation in the prevention and treatment of anemia in socially vulnerable children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5cvdrdy
Enrollment
Unknown
Registered
2022-11-27
Start date
2021-10-04
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anemia

Interventions

This is a quasi-experimental clinical trial. The sample will consist of 382 children aged 1 to 6 years. The intervention will consist of the daily use at home, once a day, of 45.4 g of a commercially
G07.203.300.456

Sponsors

Ana Paula Grotti Clemente
Lead Sponsor
Universidade Federal de Alagoas
Collaborator

Eligibility

Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: Children aged 1 to 6 years, who have a nutritional diagnosis of: very low weight for age, low weight for age or adequate weight for age (< 1 z score) or very short stature and short stature for age (< -2 Z score), according to the indicators Weight for Age and Height for Age (World Health Organization, 2006), and who at the time of recruitment are not using any other supplementation nutritional.

Exclusion criteria

Exclusion criteria: Children with a nutritional diagnosis of high weight for age (>1 z score) will be excluded from the study, as well as those whose guardians report that they have a diagnosis of neurological or genetic and autoimmune hematological diseases (sickle cell, hemolytic, sideroblastic and aplastic anemias, Fanconi anemia and thalassemia) or with a previous diagnosis of iron deficiency anemia due to other nutritional causes (megaloblastic and pernicious anemias).

Design outcomes

Primary

MeasureTime frame
Nutrisus is expected to be effective for the prevention and treatment of anemia evaluated through blood collection to measure the biochemical concentrations of hemoglobin and ferritin. It is expected to find a 38% lower prevalence of anemia in children who received powdered micronutrient sachets when compared to the control group It is expected that the nutritional supplement will be effective for the prevention and treatment of anemia evaluated by means of blood collection to measure the biochemical concentrations of hemoglobin. It is expected to find a 40% reduction in the prevalence of anemia in children after the period of nutritional supplementation.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactAna Paula Clemente

Universidade Federal de Alagoas

anagrotticlemente@gmail.com+55-82-32141041

Outcome results

None listed

Source: REBEC (via WHO ICTRP)